| Filed On | Filing |
|---|---|
| 07 Oct 2026 |
8-K: Regulation FD Disclosure
2 Forward-Looking Statements & Safe Harbor Except for historical information set forth herein, the matters set forth in this presentation contain forward-looking statements within the meaning of the safe harbor provisions of the U.S. Pri... |
| 10 Sep 2026 |
8-K: Regulation FD Disclosure
Westlake Village, Calif. – September 10, 2026 - Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced that Bradley Burnam, C... |
| 09 Sep 2026 |
8-K: Regulation FD Disclosure
Brings internationally recognized expertise in immunology, cytokine biology, host-microbe interactions and public health |
| 18 Aug 2026 | 8-K: Unregistered Sales of Equity Securities |
| 17 Aug 2026 | 8-K: Regulation FD Disclosure |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 28 Jul 2026 | 8-K: Regulation FD Disclosure |
| 07 Jul 2026 | 8-K: Regulation FD Disclosure |
| 03 Jun 2026 | 8-K: Regulation FD Disclosure |
| 01 Jun 2026 | 8-K: Regulation FD Disclosure |
| 27 May 2026 | 8-K: Regulation FD Disclosure |
| 19 May 2026 | 8-K: Regulation FD Disclosure |
| 18 May 2026 | 8-K: Regulation FD Disclosure |
| 11 May 2026 | 8-K: Results of Operations and Financial Condition |
| 31 Mar 2026 | 8-K: Results of Operations and Financial Condition |
| 24 Mar 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more |
| 17 Feb 2026 | 8-K: Regulation FD Disclosure |
| 09 Feb 2026 | 8-K: Regulation FD Disclosure |
| 12 Jan 2026 | 8-K: Regulation FD Disclosure |
| 07 Jan 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
Loading...
